Progress_in_Neuro-Psychopharmacology_and_Biological_Psychiatry

<i>Progress in Neuro-Psychopharmacology & Biological Psychiatry</i>

Progress in Neuro-Psychopharmacology & Biological Psychiatry

Academic journal

Progress in Neuro-Psychopharmacology & Biological Psychiatry is a peer-reviewed academic journal publishing review articles and original research reports pertaining to neuropsychopharmacology and biological psychiatry.

Quick Facts Discipline, Language ...

Background

The journal was established in 1977 as Progress in Neuro-Psychopharmacology, obtaining its current name in 1982.[1][2] It is published eight times per year by Elsevier. The editor-in-chief is Louis Gendron (Université de Sherbrooke). According to the Journal Citation Reports, the journal has a 2022 impact factor of 5.6.[3]

References

  1. [1]
    "Progress in Neuro-Psychopharmacology". NLM Catalog. Retrieved 12 September 2015.
  2. [2]
    "Progress in Neuro-Psychopharmacology & Biological Psychiatry". NLM Catalog. Retrieved 12 September 2015.
  3. [3]
    "Progress in Neuro-Psychopharmacology & Biological Psychiatry". 2022 Journal Citation Reports. Web of Science (Science ed.). Clarivate Analytics. 2023.


Stub icon 1 Stub icon 2

This article about a neuroscience journal is a stub. You can help Wikipedia by expanding it.

See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.

Stub icon 1 Stub icon 2

This article about a psychiatry journal is a stub. You can help Wikipedia by expanding it.

See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.

Stub icon 1 Stub icon 2

This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it.

See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.
Share this article:

This article uses material from the Wikipedia article Progress_in_Neuro-Psychopharmacology_and_Biological_Psychiatry, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.